BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 848902)

  • 1. [Multiple sclerosis: a multi-specific immune deficiency disease].
    Lamoureux G; Toupin J; Leyva F
    Ann Immunol (Paris); 1977; 128(1-2):531-6. PubMed ID: 848902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunology of multiple sclerosis. Recent data and therapeutic perspectives].
    Tourbah A; Fontaine B; Lyon-Caen O
    Rev Neurol (Paris); 1993; 149(6-7):373-84. PubMed ID: 8303156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the rationale for immunomodulating therapies in multiple sclerosis.
    Lisak RP
    Neurology; 1988 Jul; 38(7 Suppl 2):5-8. PubMed ID: 3290714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis: an immunologic perspective.
    Cui JY
    Phys Med Rehabil Clin N Am; 2005 May; 16(2):351-8. PubMed ID: 15893676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligoclonal bands and antibody responses in multiple sclerosis.
    Correale J; de los Milagros Bassani Molinas M
    J Neurol; 2002 Apr; 249(4):375-89. PubMed ID: 11967640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunopathogenesis of multiple sclerosis.
    Prat E; Martin R
    J Rehabil Res Dev; 2002; 39(2):187-99. PubMed ID: 12051463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunological basis for treatment of multiple sclerosis.
    Holmøy T; Vartdal F
    Scand J Immunol; 2007 Oct; 66(4):374-82. PubMed ID: 17850581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future research directions in multiple sclerosis therapies.
    Greenberg BM; Calabresi PA
    Semin Neurol; 2008 Feb; 28(1):121-7. PubMed ID: 18256992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific viral cause of multiple sclerosis: one virus, one disease.
    Lipton HL; Liang Z; Hertzler S; Son KN
    Ann Neurol; 2007 Jun; 61(6):514-23. PubMed ID: 17455291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. II. Response of mouse strains with selective immune defects.
    James SL; DeBlois LA
    J Immunol; 1986 May; 136(10):3864-71. PubMed ID: 3084645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
    Hermans G; Denzer U; Lohse A; Raus J; Stinissen P
    J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis: immunologic aspects.
    Lisak RP
    Ann Clin Lab Sci; 1975; 5(5):324-9. PubMed ID: 1180478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hygiene hypothesis: innate immunity, malaria and multiple sclerosis.
    Sotgiu S; Angius A; Embry A; Rosati G; Musumeci S
    Med Hypotheses; 2008; 70(4):819-25. PubMed ID: 17889443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B; Nessler S; Zhou D; Kieseier B; Hartung HP
    Nat Clin Pract Neurol; 2006 Apr; 2(4):201-11. PubMed ID: 16932551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunology of multiple sclerosis.
    Bar-Or A
    Semin Neurol; 2008 Feb; 28(1):29-45. PubMed ID: 18256985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of autoimmunity in multiple sclerosis].
    Chabas D; Liblau R
    Pathol Biol (Paris); 2000 Feb; 48(1):25-46. PubMed ID: 10729910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptides.
    Chou YK; Morrison WJ; Weinberg AD; Dedrick R; Whitham R; Bourdette DN; Hashim G; Offner H; Vandenbark AA
    J Immunol; 1994 Mar; 152(5):2520-9. PubMed ID: 7510747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
    Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
    Ziemssen T; Ziemssen F
    Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.